Eli Lilly invests in startup Abridge for clinical trial recruitment

Shiv Rao, Abridge CEO (Michael Nagle/Bloomberg via Getty Images) June 12, 2026 01:38 PM EDT StartupsPharmaHealth Tech Eli Lil­ly in­vests in start­up Abridge for clin­i­cal tri­al re­cruit­ment Ngai Yeung Health Tech Reporter Eli Lil­ly has in­vest­ed in Abridge as the health tech start­up ex­pands in­to clin­i­cal tri­al re­cruit­ment and broad­ens its reach in­to the life sci­ences. The … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER